Cameroon National Algorithm for Exposed Infant HIV Testing
This diagram outlines the process to test infants exposed to HIV at birth in Cameroon.
Consolidated HIV Guidelines for Key Populations
The new Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). They present and discuss new recommendations and consolidate a range of recommendations and guidance from current WHO guidelines.
What's New in Early Infant Diagnosis
In 2014, only 50% of all HIV-exposed infants were tested by the second month of age. Innovative approaches such as use of assays at the point-of care and adding virological testing at birth could speed up identification and ART initiation. Operational research to fully inform how to implement such innovations remains critical.
Guidelines on HIV Self-Testing and Partner Notification
Supplement to consolidated guidelines on HIV testing services
Innovations to Accelerate Access to HIV Treatment & Care for Children and Adolescents
MAC AIDS Project Brief on Innovations to Accelerate Access to Treatment and Care for Children and Adolescents Affected by HIV. The MAC AIDS Fund is designed to address unmet needs for HIV testing, treatment and care among children and adolescents in key BRICS countries (Brazil, the CEE/CIS region, India, and South Africa).
On the Fast-Track to End AIDS: UNAIDS Strategy 2016-2021
The AIDS movement, led by people living with and affected by HIV, continues to inspire the world and offer a model for a people-centred, rights-based approach to global health and social transformation. And yet, today, amid a swirl of competing and complex global concerns, we confront a serious new obstacle: the oppressive weight of complacency. This is happening when we know that if we make the right decisions and the right investments now, the end of AIDS can be within our grasp. This moment is, however, fleeting. We have a fragile window of opportunity—measured in months—in which to scale up.
Kenya Guidelines on use of Antiretroviral Drugs for Treating and Preventing HIV Infection
The Guidelines on use of Antiretroviral Drugs for Treating and Preventing HIV Infection in Kenya 2016 edition contain relevant information required by health care providers in the use of ARVs as of the date of issue. All reasonable precautions have been taken by NASCOP to verify the information contained in this guideline document. This guideline document is a publication of the National AIDS & STI Control Program, Ministry of Health Kenya.